Continuous glucose monitor accuracy in ICU patients
Part of Hormones & metabolism clinical trials.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are expected to stay in the ICU for at least 48 hours.
- You need frequent blood gas checks in the ICU.
- You do not have a skin rash or other problem where the sensor would go.
- You are willing to use a continuous glucose monitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial is testing two ways of monitoring blood sugar in intensive care patients: continuous monitoring (a sensor) versus intermittent checks. If you are in the ICU with high blood sugar and on IV insulin, this study might help find a better way to manage your levels.
This trial tests a continuous glucose monitoring system (Syai Tag) in the intensive care unit (ICU). It aims to see how well it measures blood sugar levels safely compared to standard methods.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This trial tests whether using your own continuous glucose monitor (CGM) while you are in the hospital (but not the ICU) can help better manage your blood sugar levels. If you already use a CGM at home and are admitted for at least two days, you may be able to keep using it during your stay.
Hear when a new Critically Ill Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.